THE EFFECT OF MEMBRANE-CHARACTERISTICS ON TUMOR-NECROSIS-FACTOR KINETICS DURING HEMODIALYSIS

被引:52
作者
GHYSEN, J
DEPLAEN, JF
DESTRIHOU, CV
机构
[1] Department of Nephrology, University of Louvain Medical School, Brussels
关键词
Dialysis amyloidosis; Dialysis membrane; Tumour necrosis factor; ±[!sub]2[!/sub] Microglobulin;
D O I
10.1093/ndt/5.4.270
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
We measured serum β2-M and TNFα before and after a 4-h haemodialysis performed on two membranes with different characteristics, either cuprophane (n = 40) or polyacrylonitrile (AN69) (n = 31). Kinetic studies including determinations at 0, 15, 30, 60 and 240 min were also performed during haemodialysis sessions on cuprophane (n = 14) and AN69 (n = 12). After a 240-min haemodialysis, TNFα increased on cuprophane (21.95 ± 3.46 to 37.20 ± 4.60 pg/ml, P< 0.001) but remained stable on AN69 (16.70 ±2.60 to 19.90±2.90 pg/ml, NS). Kinetic studies revealed that on cuprophane, β2-M increased progressively from 40.72 ± 4.41 to 45.71 ±4.77 mg/l (P<0.001) at 240 min with a significant increase already noted at 60 min. TNFI remained stable during the first 60 min but increased significantly at 240 min (34.14 ± 6.60 to 49.71 ± 8.78 pg/ml, P<0.001). The percentage increment in TNFI (50.5%) was significantly greater at 240 min than the percentage increment in β2M (13.4%), a finding suggestive of net generation of TNFI. On AN69, β2-M decreased progressively from 31.82 ± 2.70 to 27.30±2.26mg/l (P<0.001). TNFI a decreased transiently at 15 min but returned subsequently to control values (0 and 240 min: 25.00 ± 3.81 and 29.75 ± 3.59 pg/ml respectively, NS). Our data suggest a net release of TNFα during cuprophane but not during polyacrylonitrile haemodialysis. This release might play a role in the stimulation of β2-M production and thus in the genesis of dialysis amyloidosis. © 1990 European Dialysis and Transplant Association-European Renal Association.
引用
收藏
页码:270 / 274
页数:5
相关论文
共 15 条
[1]   ENHANCED SERUM LEVELS OF BETA-2-MICROGLOBULIN, NEOPTERIN, AND INTERFERON-GAMMA IN PATIENTS TREATED WITH RECOMBINANT TUMOR NECROSIS FACTOR-ALPHA [J].
AULITZKY, WE ;
TILG, H ;
HEROLD, M ;
BERGER, M ;
VOGEL, W ;
JUDMAIER, G ;
GASTL, G ;
MULL, B ;
FLENER, R ;
WIEGELE, J ;
PICHLER, E ;
DENZ, H ;
BOHEIM, E ;
AULITZKY, WK ;
HUBER, C .
JOURNAL OF INTERFERON RESEARCH, 1988, 8 (05) :655-664
[2]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[3]   CARPAL-TUNNEL SYNDROME AND TYPE OF DIALYSIS MEMBRANE [J].
CHANARD, J ;
BINDI, P ;
LAVAUD, S ;
TOUPANCE, O ;
MAHEUT, H ;
LACOUR, F .
BRITISH MEDICAL JOURNAL, 1989, 298 (6677) :867-868
[4]   RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR INCREASES MESSENGER-RNA LEVELS AND SURFACE EXPRESSION OF HLA-A,B ANTIGENS IN VASCULAR ENDOTHELIAL-CELLS AND DERMAL FIBROBLASTS INVITRO [J].
COLLINS, T ;
LAPIERRE, LA ;
FIERS, W ;
STROMINGER, JL ;
POBER, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (02) :446-450
[5]   CACHECTIN TUMOR NECROSIS FACTOR STIMULATES COLLAGENASE AND PROSTAGLANDIN-E2 PRODUCTION BY HUMAN SYNOVIAL-CELLS AND DERMAL FIBROBLASTS [J].
DAYER, JM ;
BEUTLER, B ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (06) :2163-2168
[6]  
DESTRIHOU CV, 1988, NEPHROL DIAL TRANSPL, V3, P552
[7]  
GOLDMAN M, 1988, NEPHROL DIAL TRANSPL, V3, P551
[8]  
LONNEMANN G, 1987, NEW ENGL J MED, V317, P963
[9]  
LONNEMANN G, 1988, KIDNEY INT, V33, P229
[10]   DETECTION OF CIRCULATING TUMOR NECROSIS FACTOR AFTER ENDOTOXIN ADMINISTRATION [J].
MICHIE, HR ;
MANOGUE, KR ;
SPRIGGS, DR ;
REVHAUG, A ;
ODWYER, S ;
DINARELLO, CA ;
CERAMI, A ;
WOLFF, SM ;
WILMORE, DW .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (23) :1481-1486